Abstract GS3-05: Fulvestrant-palbociclib vs continuing aromatase inhibitor-palbociclib upon detection of circulating ESR1 mutation in HR+ HER2- metastatic breast cancer patients: R... by Bidard, François-Clément, Hardy-Bessard, Anne-Claire, Bachelot, Thomas, Pierga, Jean-Yves, Canon, Jean-Luc, Clatot, Florian, Andre, Fabrice, De La Motte Rouge, Thibault, Pistilli, Barbara, Dalenc, Florence, Dohollou, Nadine, Arsene, Olivier, Petit, Thierry, Riedl, Cécilia, Morvan, François, Marti, Adina, Lachaier, Emma, Achille, Mihaela, Gozy, Michel, Escande, Anne, Mille, Dominique, Trouboul, Fanny, Arnould, Laurent, Bieche, Ivan, Pradines, Anne, Lemonnier, Jerome, Berger, Frederique, Delaloge, Suzette

Get full text

Trastuzumab deruxtecan in previously treated HER2‐positive metastatic or unresectable breast cancer: Real‐life data from the temporary use authorization program in France by Petit, Thierry, Hajjaji, Nawale, Antoine, Eric‐Charles, Benderra, Marc‐Antoine, Gozy, Michel, Foa, Cyril, Mouysset, Jean‐Loup, Grenier, Julien, Mousseau, Mireille, Mailliez, Audrey, Saghatchian, Mahasti, Lachaier, Emma, Desmoulins, Isabelle, Hennequin, Audrey, Maes, Patricia, Loirat, Delphine, Ricci, Francesco, Diéras, Véronique, Berton, Dominique, Tiong, Florence Lai, Teixeira, Luis, Dohollou, Nadine, Lévy, Christelle, Bachelot, Thomas, Pierga, Jean‐Yves

Get full text

Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised... by Bidard, François-Clément, Hardy-Bessard, Anne-Claire, Dalenc, Florence, Bachelot, Thomas, Pierga, Jean-Yves, de la Motte Rouge, Thibault, Sabatier, Renaud, Dubot, Coraline, Ferrero, Jean Marc, Ladoire, Sylvain, Levy, Christelle, Mouret-Reynier, Marie-Ange, Lortholary, Alain, Grenier, Julien, Chakiba, Camille, Stefani, Laetitia, Plaza, Jérôme Edouard, Clatot, Florian, Teixeira, Luis, D'Hondt, Véronique, Vegas, Hélène, Derbel, Olfa, Garnier-Tixidre, Claire, Canon, Jean-Luc, Pistilli, Barbara, André, Fabrice, Bièche, Ivan, Callens, Céline, Lemonnier, Jérôme, Delaloge, Suzette, PISTILLI, Barbara, DALENC, Florence, BACHELOT, Thomas, SABATIER, Renaud, DUBOT, Coraline, FRENEL, Jean-Sébastien, FERRERO, Jean-Marc, LADOIRE, Sylvain, LEVY, Christelle, MOURET-REYNIER, Marie-Ange, HARDY-BESSARD, Anne-Claire, LORTHOLARY, Alain, GRENIER, Julien, CHAKIBA, Camille, STEFANI, Laetitia, SOULIE, Patrick, PLAZA, Jérôme Edouard, CLATOT, Florian, TEIXEIRA, Luis, D'HONDT, Véronique, VEGAS, Hélène, DERBEL, Olfa, GARNIER TIXIDRE, Claire, CHENEAU, Caroline, PAITEL, Jean-François, BERNARD-MARTY, Chantal, SPAETH, Dominique, MOULLET, Isabelle, DEIANA, Laura, GREILSAMER, Charlotte, VENAT-BOUVET, Laurence, DELECROIX, Valérie, MELIS, Adrien, ORFEUVRE, Hubert, NGUYEN, Suzanne, LEGOUFFE, Eric, ZANNETTI, Alain, LE SCODAN, Romuald, DOHOLLOU, Nadine, DALIVOUST, Philippe, ARSENE, Olivier, MARQUES, Nathalie, PETIT, Thierry, MOLLON, Delphine, DAUBA, Jérôme, BONNIN, Nathalie, GARDNER, Miriam, MARTI, Adina, LEVACHE, Charles-Briac, LACHAIER, Emma, ACHILLE, Mihaela, VALMAR, Christophe, BOUAITA, Ryan, MEDIONI, Jacques, FOA, Cyril, DEL PIANO, Francesco, GOZY, Michel, ESCANDE, Anne, LEDUC, Nicolas, LUCAS, Brigitte, AMMARGUELLAT, Hanifa, NAJEM, Abeer, TROUBOUL, Fanny, DESCLOS, Hervé, MAYEUR, Didier, LORCHEL, Fabrice, BOUDRANT, Axelle, GISSEROT, Olivier, ALLEAUME, Corinne, DE GRAMONT, Aimery

Get full text

Abstract P1-18-16: First line aromatase inhibitor (AI) + palbociclib with randomized switch to fulvestrant + palbociclib upon detection of circulating ESR1 mutation in HR+ HER2- me... by Delaloge, Suzette, Hardy-Bessard, Anne-Claire, Bachelot, Thomas, Pierga, Jean-Yves, Canon, Jean-Luc, Clatot, Florian, André, Fabrice, Rouge, Thibault De La Motte, Pistilli, Barbara, Dalenc, Florence, Dohollou, Nadine, Arsene, Olivier, Petit, Thierry, Riedl, Cecilia, Morvan, François, Marti, Adina, Lachaier, Emma, Achille, Mihaela, Gozy, Michel, Escande, Anne, Mille, Dominique, Trouboul, Fanny, Marques, Sandrine, Lemonnier, Jerome, Berger, Frederique, Bidard, François-Clément

Get full text

Abstract P2-13-26: Trastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer (BC): First real-life data from the cohort temporary authoriz... by Petit, Thierry, Hajjaji, Nawale, Antoine, Eric-Charles, Benderra, Marc-Antoine, Gozy, Michel, Foa, Cyril, Mouysset, Jean-Loup, Grenier, Julien, Mousseau, Mireille, Mailliez, Audrey, Saghatchian, Mahasti, Lachaier, Emma, Desmoulins, Isabelle, Hennequin, Audrey, Maes, Patricia, Loirat, Delphine, Ricci, Francesco, Diéras, Véronique, Berton, Dominique, Tiong, Florence Lai, Teixeira, Luis, Dohollou, Nadine, Lévy, Christelle, Bachelot, Thomas, Pierga, Jean-Yves

Get full text

A Lymph Node Ratio of 10% Is Predictive of Survival in Stage III Colon Cancer: A French Regional Study by Sabbagh, Charles, Mauvais, François, Cosse, Cyril, Rebibo, Lionel, Joly, Jean-Paul, Dromer, Didier, Aubert, Christine, Carton, Sophie, Dron, Bernard, Dadamessi, Innocenti, Maes, Bernard, Perrier, Guillaume, Manaouil, David, Fontaine, Jean-François, Gozy, Michel, Panis, Xavier, Foncelle, Pierre Henri, de Fresnoy, Hugues, Leroux, Fabien, Vaneslander, Pierre, Ghighi, Caroline, Regimbeau, Jean-Marc

Get full text

P-598 Concurrent chemo-radiotherapy in locally advanced non-small cell lung cancer (NSCLC): A multicenter randomized phase II study by Spano, Jean-Philippe, Diana, Christian, Pailler, Marie-Christine, Morin, Franck, Bouillet, Thierry, Gozy, Michel, Labrune, Sylvie, Gervais, Radj, Virally, Jerome, Kohn, Maurice, Breau, Jean-Luc, Valeyre, Dominique, Chinet, Dominique, Morere, Jean-Francois

Get full text

Cross resistance and collateral sensitivity between cytotoxic drugs and radiation in two human bladder cell lines by Pauwels, Olivier, Gozy, Michel, Van Houtte, Paul, Pasteels, Jean-Lambert, Atassi, Ghanem, Kiss, Robert

Get full text